NCT00563810View on ClinicalTrials.gov

Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of MYO-029

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

October 31, 2004

Study Completion Date

April 30, 2006

Conditions
Healthy
Interventions
DRUG

MYO-029

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00563810 - Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of MYO-029 | Biotech Hunter | Biotech Hunter